BIOA
NASDAQ · Pharmaceuticals
Bioage Labs Inc
$16.43
+0.32 (+1.99%)
Open$16.32
Previous Close$16.11
Day High$16.54
Day Low$15.47
52W High$24.00
52W Low$2.88
Volume—
Avg Volume595.3K
Market Cap878.47M
P/E Ratio—
EPS$-2.04
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
-20.0% upside
Current
$16.43
$16.43
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 148.13M | 155.08M | 129.49M |
| Net Income | 34.83M | 38.64M | 27.42M |
| Profit Margin | 23.5% | 24.9% | 21.2% |
| EBITDA | 58.57M | 58.31M | 46.56M |
| Free Cash Flow | 41.37M | 59.47M | 31.55M |
| Rev Growth | -6.9% | -7.9% | +7.7% |
| Debt/Equity | 0.90 | 0.74 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |